Works about CHIMERIC antigen receptors


Results: 3503
    1

    T cells in cancer: mechanistic insights and therapeutic advances.

    Published in:
    Biomarker Research, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40364-025-00807-w
    By:
    • Pu, Jingjing;
    • Liu, Ting;
    • Zhou, Yi;
    • Chen, Mengping;
    • Fu, Xuehang;
    • Wan, Yike;
    • Wang, Junying;
    • Chen, Binzhen;
    • Sharma, Amit;
    • Lukacs-Kornek, Veronika;
    • Schmidt-Wolf, Ingo G.H.;
    • Hou, Jian
    Publication type:
    Article
    2
    3
    4

    Targets for CAR Therapy in Multiple Myeloma.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 13, p. 6051, doi. 10.3390/ijms26136051
    By:
    • Bezborodova, Olga A.;
    • Trunova, Galina V.;
    • Nemtsova, Elena R.;
    • Khokhlova, Varvara A.;
    • Venediktova, Julia B.;
    • Morozova, Natalia B.;
    • Vorontsova, Maria S.;
    • Plyutinskaya, Anna D.;
    • Zharova, Elena P.;
    • Shegai, Peter V.;
    • Kaprin, Andrey D.
    Publication type:
    Article
    5

    Bio-functional hydrogel coated membranes to decrease T-cell exhaustion in manufacturing of CAR T-cells.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1513148
    By:
    • López Ruiz, Aida;
    • Slaughter, Eric;
    • Bomb, Kartik;
    • Swedzinski, Samantha L.;
    • LeValley, Paige J.;
    • Yun, Zaining;
    • McCoskey, Jacob;
    • Levine, Kara;
    • Steen, Jonathan;
    • Almasian, Joseph;
    • Chatterjee, Aparajita;
    • Carbrello, Christina;
    • Chang, Dustin S.;
    • Fuseini, Hubaida;
    • Abassi, Yama A.;
    • Lenhoff, Abraham M.;
    • Fromen, Catherine A.;
    • Kloxin, April M.
    Publication type:
    Article
    6

    Does a natural killer need a CAR?

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1606126
    By:
    • Wang, Kangbo;
    • Zhang, Yumo;
    • Han, Zhibo;
    • Wang, Youwei
    Publication type:
    Article
    7
    8
    9
    10
    11

    Top advances of the year: Sarcoma.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35965
    By:
    • Vierra, Mason;
    • Brett, Jamie;
    • Wang, Jiping
    Publication type:
    Article
    12

    Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60980-2
    By:
    • Atanackovic, Djordje;
    • Luetkens, Tim;
    • Schneider, Dina;
    • Hu, Peirong;
    • Wang, Xu;
    • Shetty, Amol C.;
    • Tallon, Luke;
    • Patel, Imari;
    • Singh, Rohan;
    • Gebru, Etse;
    • Mulatu, Rediet;
    • Omili, Destiny;
    • Yamoah, Daniel;
    • Fan, Xiaoxuan;
    • Matsangos, Aerielle;
    • Lesho, Patricia;
    • Dietze, Kenneth A.;
    • Fromowitz, Ariel A.;
    • Hankey, Kim G.;
    • Dahiya, Saurabh
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice.

    Published in:
    Science Translational Medicine, 2025, v. 17, n. 805, p. 1, doi. 10.1126/scitranslmed.ado9511
    By:
    • Rossari, Federico;
    • Alvisi, Giorgia;
    • Cusimano, Melania;
    • Beretta, Stefano;
    • Birocchi, Filippo;
    • Ambrosecchia, Deborah I.;
    • Vitaloni, Ottavia;
    • Brombin, Chiara;
    • Rancoita, Paola Maria Vittoria;
    • Canu, Tamara;
    • Orofino, Giorgio;
    • Annoni, Andrea;
    • Gentner, Bernhard;
    • Squadrito, Mario Leonardo;
    • Genua, Marco;
    • Ostuni, Renato;
    • Merelli, Ivan;
    • Coltella, Nadia;
    • Naldini, Luigi
    Publication type:
    Article
    20

    Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01321-w
    By:
    • Einarsdottir, Sigrun;
    • Lobaugh, Stephanie;
    • Luan, Danny;
    • Gomez-Llobell, Marina;
    • Subramanian, Padmapriya;
    • Devlin, Sean;
    • Chung, David;
    • Dahi, Parastoo B.;
    • Falchi, Lorenzo;
    • Giralt, Sergio;
    • Landau, Heather;
    • Lesokhin, Alexander M.;
    • Lin, Richard;
    • Lue, Jennifer;
    • Mailankody, Sham;
    • Palomba, M. Lia;
    • Park, Jae H.;
    • Salles, Gilles;
    • Scordo, Michael;
    • Escribano-Serrat, Silvia
    Publication type:
    Article
    21
    22
    23

    The Coming of Age of Theranostic Cells.

    Published in:
    Journal of Nanotheranostics, 2025, v. 6, n. 2, p. 15, doi. 10.3390/jnt6020015
    By:
    • Moghimi, Seyed Moein;
    • Schwartz Jr., Simó
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Challenges and opportunities for cancer stem cell‐targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell‐dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.

    Published in:
    Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 6, p. 1, doi. 10.1002/jbt.23719
    By:
    • Alqarni, Abdullah;
    • Jasim, Saade Abdalkareem;
    • Altalbawy, Farag M. A.;
    • Kaur, Harpreet;
    • Kaur, Irwanjot;
    • Rodriguez‐Benites, Carlos;
    • Deorari, Mahamedha;
    • Alwaily, Enas R.;
    • Al‐Ani, Ahmed M.;
    • Redhee, Ahmed H.
    Publication type:
    Article
    44
    45
    46
    47
    48

    Glycan-directed CAR-T cells.

    Published in:
    Glycobiology, 2018, v. 28, n. 9, p. 656, doi. 10.1093/glycob/cwy008
    By:
    • Steentoft, Catharina;
    • Migliorini, Denis;
    • King, Tiffany R;
    • Mandel, Ulla;
    • June, Carl H;
    • Posey, Avery D
    Publication type:
    Article
    49

    Cancer Immunotherapy.

    Published in:
    Glycobiology, 2018, v. 28, n. 9, p. 638, doi. 10.1093/glycob/cwy069
    By:
    • Pearce, Oliver M T;
    • Läubli, Heinz
    Publication type:
    Article
    50